Global Prevalence of Helicobacter pylori Infection-Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta-Analysis
- PMID: 40018952
- DOI: 10.1111/hel.70021
Global Prevalence of Helicobacter pylori Infection-Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta-Analysis
Abstract
Background: Helicobacter pylori (H. pylori) is the major cause of gastric mucosal precancerous lesions in adulthood, but its impact on pediatric patients remains unclear. We aimed to investigate H. pylori-induced gastric precancerous lesions in children and adolescents globally and analyze their influencing factors for related disease management and prevention.
Materials and methods: We conducted a comprehensive literature search in major databases to identify studies including pediatric patients with gastric precancerous lesions and H. pylori infection status. Prevalence rates were computed using random-effects or fixed-effect models. A stratified analysis was conducted based on location, age, universal health coverage (UHC), and publication time.
Results: Among the 3359 relevant articles screened, 24 studies (7036 participants) met the inclusion criteria. The overall prevalence of precancerous lesions in H. pylori-infected patients was 17.2%, in which atrophic gastritis (AG) and intestinal metaplasia (IM) were 13.5% and 3.6%, respectively. Precancerous lesion rates in infected individuals across different regions were as follows: Africa at 33.8% (AG: 32.6%), Latin America at 22.1% (AG: 17.9%, IM: 4.0%), Asia at 18.1% (AG: 12.4%, IM: 4.4%, Dysplasia: 1.2%), and Europe at 6.3% (AG: 4.3%, IM: 1.7%). Infected adolescents (> 10 years) exhibited a higher prevalence of precancerous lesions than younger children (≤ 10 years) at 14.2% (AG: 9.7%, IM: 2.9%) versus 3.4% (AG: 2.3%, IM: 1.1%), respectively. The prevalence of precancerous lesions in infected patients was higher in areas with low-medium UHC compared with high UHC (24.0% vs. 12.5%).
Conclusions: H. pylori infection causes significant gastric mucosal precancerous lesions in pediatric patients, representing a major concern for this population and a previously neglected area. Future in-depth investigations and proper management for related disease prevention are warranted.
Trial registration: PROSPERO number: CRD42023424683.
Keywords: Helicobacter pylori; children and adolescents; gastric cancer; gastritis; precancerous lesions.
© 2025 John Wiley & Sons Ltd.
References
-
- J. S. Park, J. S. Jun, J. H. Seo, H. S. Youn, and K. H. Rhee, “Changing Prevalence of Helicobacter pylori Infection in Children and Adolescents,” Clinical and Experimental Pediatrics 64, no. 1 (2021): 21–25.
-
- P. Correa and M. B. Piazuelo, “The Gastric Precancerous Cascade,” Journal of Digestive Diseases 13, no. 1 (2012): 2–9.
-
- D. Rothenbacher, M. Winkler, T. Gonser, G. Adler, and H. Brenner, “Role of Infected Parents in Transmission of Helicobacter pylori to Their Children,” Pediatric Infectious Disease Journal 21, no. 7 (2002): 674–679.
-
- D. Ortiz‐Princz, G. Daoud, A. Salgado‐Sabel, and M. E. Cavazza, “Helicobacter pylori Infection in Children: Should it be Carefully Assessed?,” European Review for Medical and Pharmacological Sciences 20, no. 9 (2016): 1798–1813.
-
- Y. H. Park and N. Kim, “Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer,” Journal of Cancer Prevention 20, no. 1 (2015): 25–40.
Publication types
MeSH terms
Grants and funding
- U1604174/National Natural Science Foundation of China
- 20170123/Health Commission of Henan Province-Province and Ministry Co-construction Project
- SBGJ202002004/Health Commission of Henan Province-Province and Ministry Co-construction Project
- 51282/Health Commission of Henan Province-Research Innovative Talents Project
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous